Skip to main content
. Author manuscript; available in PMC: 2022 Feb 23.
Published in final edited form as: Lancet Healthy Longev. 2021 May 21;2(6):e340–e351. doi: 10.1016/s2666-7568(21)00089-1

Table 3: Predicted probabilities of diabetes treatment coverage from multivariable logistic regression models.

Predicted probabilities of coverage with 95% confidence intervals are reported from multivariable logistic regression models. Predicted probabilities were generated as average adjusted predictions for categorical variables (sex, educational attainment, and wealth) and adjusted predictions at representative values for continuous variables (age and BMI). Wealth quintile was not available in n=7 surveys (appendix p 45). Each column represents a diabetes treatment that serves as the model’s dependent variable. The covariates in the model include all row variables and country-fixed effects. Illustrative values for age and body mass index are presented; these variables were included as continuous variables in the models using restricted cubic splines at knots of 5%, 27.5%, 50%, 72.5%, and 95%. Survey weighting and clustering at the country level were accounted for in the models. N/A=not applicable.

Glucose-lowering medication Antihypertensive medication Cholesterol-lowering medication Diet counseling Exercise counseling Weight-loss counseling
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Sex
 Male 44.9 (41.9–47.9) 34.4 (31.2–37.6) 7.0 (5.3–8.7) 31.3 (28.9–33.6) 27.7 (25.3–25.3) 28.8 (25.7–32.0)
 Female 52.2 (49.9–54.5) 44.6 (41.8–47.3) 6.7 (5.5–7.9) 33.5 (31.4–35.6) 29.8 (27.8–31.8) 34.3 (31.5–37.1)
Age (years)
 30 24.0 (18.4–29.6) 20.6 (13.4–27.8) N/A 13.1 (9.7–16.5) 12.1 (8.8–15.5) 17.2 (11.3–23.2)
 40 38.6 (34.8–42.4) 29.4 (23.8–35.0) 3.7 (1.5–5.8) 25.5 (22.4–28.6) 22.7 (19.6–25.7) 27.9 (23.8–32.0)
 50 50.2 (46.7–53.6) 38.2 (34.2–42.1) 6.6 (5.0–8.3) 34.3 (31.5–37.1) 30.4 (27.6–33.3) 32.7 (29.2–36.3)
 60 60.1 (56.6–63.7) 49.1 (45.4–52.7) 7.9 (6.0–9.8) 41.6 (38.8–44.4) 36.7 (34.0–39.4) 38.8 (35.4–42.2)
Body mass index
 20 45.6 (41.2–50.0) 30.7 (25.3–36.1) 3.5 (1.8–5.2) 23.0 (19.8–26.1) 18.7 (15.7–21.7) N/A
 25 48.7 (45.4–52.0) 36.6 (33.4–39.9) 6.5 (3.9–9.1) 31.2 (28.3–34.0) 28.3 (25.5–31.1) 28.2 (19.5–36.9)
 30 50.3 (47.5–53.1) 42.9 (39.8–46.1) 6.9 (5.2–8.6) 35.2 (32.5–37.9) 30.9 (28.2–33.5) 32.1 (28.2–36.0)
 35 51.7 (47.7–55.7) 47.3 (43.0–51.6) 8.2 (6.4–10.0) 40.3 (36.4–44.2) 35.6 (31.8–39.3) 37.6 (33.4–41.7)
Education
 None 37.7 (32.9–42.6) 34.6 (30.4–38.7) 6.6 (4.5–8.8) 25.0 (21.4–28.7) 19.8 (16.2–23.4) 23.8 (18.5–29.1)
 Primary 49.0 (45.8–52.2) 40.9 (37.2–44.6) 7.2 (5.8–8.6) 33.3 (30.5–36.0) 28.2 (25.5–30.9) 32.6 (29.0–36.3)
 Secondary or more 53.0 (49.9–56.0) 42.4 (39.0–45.7) 6.6 (4.6–8.5) 34.7 (32.0–37.5) 32.9 (30.1–35.7) 34.6 (31.2–37.9)
Wealth quintile
 1 (poorest) 47.8 (44.0–51.7) 40.4 (36.1–44.8) 7.2 (5.3–9.1) 29.7 (26.2–33.2) 25.5 (22.0–28.9) 27.6 (23.1–32.1)
 2 44.9 (41.2–48.6) 39.7 (35.2–44.1) 6.5 (4.0–9.1) 27.8 (24.7–30.9) 25.3 (22.0–28.6) 26.9 (22.8–31.1)
 3 45.6 (41.6–49.6) 41.6 (36.7–46.4) 5.1 (3.8–6.3) 29.4 (26.2–32.6) 27.0 (23.8–30.1) 30.1 (25.9–34.2)
 4 50.8 (47.2–54.4) 40.4 (36.3–44.5) 7.2 (5.3–9.1) 35.7 (32.0–39.4) 30.2 (26.4–34.0) 33.2 (28.6–37.9)
 5 (richest) 54.5 (50.3–58.7) 39.6 (35.1–44.2) 8.5 (5.1–12.0) 38.7 (34.9–42.5) 35.3 (31.7–38.9) 39.7 (35.0–44.4)